Efficacy of Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Japanese Women Aged 20 to 25 Years: Interim Analysis of a Phase 2 Double-Blind, Randomized, Controlled Trial
Efficacy of Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Japanese Women Aged 20 to 25 Years: Interim Analysis of a Phase 2 Double-Blind, Randomized, Controlled Trial